These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 27627929)

  • 1. Severe GHB withdrawal delirium managed with dexmedetomidine.
    Tay EM; Graham RI; Day RO
    Med J Aust; 2016 Sep; 205(6):251-2. PubMed ID: 27627929
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical management of gamma-hydroxybutyrate (GHB) withdrawal delirium with CIWA-Ar protocol.
    Liao PC; Chang HM; Chen LY
    J Formos Med Assoc; 2018 Dec; 117(12):1124-1127. PubMed ID: 29933901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of dexmedetomidine to treat delirium primarily caused by cannabis.
    Leikin JB; Amusina O
    Am J Emerg Med; 2017 Mar; 35(3):524.e1-524.e2. PubMed ID: 28277253
    [No Abstract]   [Full Text] [Related]  

  • 4. Dexmedetomidine-induced fever and delirium: A case report.
    Straw LB; Dodson CR; Schrift DS
    J Clin Pharm Ther; 2018 Jun; 43(3):430-433. PubMed ID: 29574851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Excited delirium syndrome after withdrawal from 10 days long recreationally used GHB.
    Corstens D
    J Forensic Leg Med; 2018 Feb; 54():74-75. PubMed ID: 29328965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Severe delirium after GHB abuse].
    Sundal EV; Giil LM
    Tidsskr Nor Laegeforen; 2020 Feb; 140(2):. PubMed ID: 32026868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two cases of acute dexmedetomidine withdrawal syndrome following prolonged infusion in the intensive care unit: Report of cases and review of the literature.
    Kukoyi A; Coker S; Lewis L; Nierenberg D
    Hum Exp Toxicol; 2013 Jan; 32(1):107-10. PubMed ID: 23111887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two cases of severe gamma-hydroxybutyrate withdrawal delirium on a psychiatric unit: recommendations for management.
    Rosenberg MH; Deerfield LJ; Baruch EM
    Am J Drug Alcohol Abuse; 2003 May; 29(2):487-96. PubMed ID: 12765217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of dexmedetomidine therapy on the management of severe alcohol withdrawal syndrome in critically ill patients.
    Frazee EN; Personett HA; Leung JG; Nelson S; Dierkhising RA; Bauer PR
    J Crit Care; 2014 Apr; 29(2):298-302. PubMed ID: 24360597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. gamma-Hydroxybutyrate withdrawal and chloral hydrate.
    Hutto B; Fairchild A; Bright R
    Am J Psychiatry; 2000 Oct; 157(10):1706. PubMed ID: 11007738
    [No Abstract]   [Full Text] [Related]  

  • 11. Using dexmedetomidine as adjunctive therapy for patients with severe alcohol withdrawal syndrome: another piece of the puzzle.
    Savel RH; Kupfer Y
    Crit Care Med; 2014 May; 42(5):1298-9. PubMed ID: 24736345
    [No Abstract]   [Full Text] [Related]  

  • 12. [GHB withdrawal delirium].
    Stijnenbosch PJ; Zuketto C; Beijaert PJ; Maat A
    Ned Tijdschr Geneeskd; 2010; 154():A1086. PubMed ID: 20132572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged sedation in critically ill children: is dexmedetomidine a safe option for younger age? An off-label experience.
    Sperotto F; Mondardini MC; Vitale F; Daverio M; Campagnano E; Ferrero F; Rossetti E; Vasile B; Dusio MP; Ferrario S; Savron F; Brugnaro L; Amigoni A;
    Minerva Anestesiol; 2019 Feb; 85(2):164-172. PubMed ID: 30394067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dexmedetomidine in the treatment of withdrawal syndromes in cardiothoracic surgery patients.
    Baddigam K; Russo P; Russo J; Tobias JD
    J Intensive Care Med; 2005; 20(2):118-23. PubMed ID: 15855224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gamma-hydroxybutyrate withdrawal syndrome: dangerous but not well-known.
    van Noorden MS; van Dongen LC; Zitman FG; Vergouwen TA
    Gen Hosp Psychiatry; 2009; 31(4):394-6. PubMed ID: 19555805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial.
    Pandharipande PP; Pun BT; Herr DL; Maze M; Girard TD; Miller RR; Shintani AK; Thompson JL; Jackson JC; Deppen SA; Stiles RA; Dittus RS; Bernard GR; Ely EW
    JAMA; 2007 Dec; 298(22):2644-53. PubMed ID: 18073360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baclofen and gamma-hydroxybutyrate withdrawal.
    LeTourneau JL; Hagg DS; Smith SM
    Neurocrit Care; 2008; 8(3):430-3. PubMed ID: 18266111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Gamma Hydroxybutyrate Withdrawal in a Pregnant Female: A Case Report.
    Joyce S; Lea S; Woolner M; Leddy A
    J Addict Med; 2024 May-Jun 01; 18(3):342-344. PubMed ID: 38345233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of Propofol Plus Dexmedetomidine in Patients Experiencing Severe Alcohol Withdrawal in the Intensive Care Unit.
    Love K; Zimmermann AE
    J Clin Pharmacol; 2020 Apr; 60(4):439-443. PubMed ID: 31663139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Niche Roles for Dexmedetomidine in the Intensive Care Unit.
    Wiegand A; Behal M; Robbins B; Bissell B; Pandya K; Mefford B
    Ann Pharmacother; 2023 Oct; 57(10):1207-1220. PubMed ID: 36721323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.